subacut
scleros
panenceph
sspe
rare
fatal
outcom
measl
viru
mev
infect
sspe
develop
prolong
persist
mutat
mev
call
sspe
viru
although
combin
therapi
use
interferon
inosiplex
ribavirin
appear
prolong
surviv
time
extent
current
effect
treatment
complet
cure
sspe
new
treatment
strategi
greatli
need
studi
adopt
rna
interfer
rnai
strategi
examin
whether
small
interf
rna
sirna
use
inhibit
replic
mev
sspe
viru
report
sirna
target
l
mrna
mev
either
synthet
sirna
gener
pcpur
express
plasmid
effect
specif
inhibit
replic
mev
sspe
viru
without
exhibit
cytotox
effect
l
protein
mev
major
compon
rnadepend
rna
polymeras
essenti
viral
rna
replic
yet
least
abund
among
mev
protein
express
therefor
mrna
encod
l
protein
would
good
target
rnai
strategi
present
result
impli
possibl
sirna
mev
l
mrna
among
potenti
candid
use
treat
patient
sspe
measl
viru
mev
member
genu
morbilliviru
famili
paramyxovirida
nonseg
negativestrand
rna
viru
mev
genom
contain
six
gene
n
pcv
f
h
l
lamb
kolakofski
pcv
gene
transcrib
overlap
pcv
mrna
gene
singl
mrna
mev
gene
flank
extragen
termin
leader
trailer
region
connect
short
stretch
conserv
sequenc
gene
boundari
sequenc
consist
three
region
call
transcript
end
intercistron
transcript
start
sequenc
function
transcript
regulatori
sequenc
l
mrna
encod
l
protein
contain
catalyt
motif
common
rnadepend
rna
polymeras
negativestrand
rna
virus
subacut
scleros
panenceph
sspe
rare
fatal
outcom
mev
infect
estim
approxim
million
mevinfect
individu
develop
sspe
caus
mutat
mev
sspe
viru
prolong
incub
period
averag
year
okuno
et
al
although
combin
therapi
use
interferon
ifn
inosiplex
anlar
et
al
gascon
ribavirin
hosoya
et
al
appear
improv
clinic
condit
surviv
time
extent
current
specif
treatment
avail
cure
patient
sspe
new
treatment
strategi
sspe
greatli
need
rna
interfer
rnai
involv
small
interf
rna
sirna
known
play
import
role
host
defens
mechan
plant
insect
bernstein
et
al
elbashir
et
al
hamilton
baulcomb
zamor
et
al
sirna
function
mammalian
cell
well
elbashir
et
al
gitlin
et
al
mccaffrey
et
al
paddison
et
al
paul
et
al
rubinson
et
al
xia
et
al
shown
suppress
replic
wide
varieti
virus
includ
human
immunodefici
viru
coburn
cullen
huelsmann
et
al
lee
et
al
takaku
hepat
b
c
virus
radhakrishnan
et
al
randal
rice
sever
acut
respiratori
syndrom
sar
coronaviru
wang
et
al
wu
et
al
human
rhinoviru
phipp
et
al
human
respiratori
syncyti
viru
parainfluenza
viru
barik
bitko
et
al
zhang
et
al
latter
two
belong
famili
paramyxovirida
howev
littl
inform
avail
far
rnai
mev
sspe
viru
infect
report
sirna
target
l
mrna
mev
either
synthet
one
gener
pcpur
express
plasmid
effect
inhibit
replic
mev
sspe
viru
knowledg
first
report
describ
effect
inhibit
mev
sspe
viru
mean
sirna
chemic
synthes
rna
oligonucleotid
purchas
japan
bio
servic
saitama
japan
order
increas
stabil
sirna
overhang
strand
made
thymidin
residu
instead
uridin
elbashir
et
al
elbashir
et
al
sirna
duplex
prepar
describ
previous
takigawa
et
al
brief
sens
antisens
rna
oligonucleotid
heat
c
min
incub
c
min
anneal
buffer
mm
potassium
acet
mm
hepeskoh
ph
mm
magnesium
acet
sirna
thu
prepar
transfect
cultur
cell
use
lipofectamin
invitrogen
accord
manufactur
instruct
plasmid
vector
express
sirna
construct
report
previous
takigawa
et
al
modif
briefli
chemic
synthes
dna
oligonucleotid
purchas
espec
oligo
servic
corp
tsukuba
ibaraki
japan
sens
antisens
dna
oligonucleotid
anneal
clone
uniqu
bspmi
site
pcpur
downstream
promot
miyagishi
taira
pcpur
kindli
provid
dr
k
taira
graduat
school
engin
univers
tokyo
tokyo
japan
sirna
express
plasmid
empti
control
vector
transfect
cultur
cell
use
fugen
reagent
roch
accord
manufactur
instruct
marmoset
blymphoblastoid
cell
line
describ
previous
itoh
et
al
katayama
et
al
kobun
et
al
shibahara
et
al
veroslam
cell
ono
et
al
kind
gift
dr
yanagi
depart
virolog
kyusyu
univers
graduat
school
medicin
fukuoka
japan
maintain
dulbecco
modif
eagl
minimum
essenti
medium
supplement
fetal
calf
serum
gml
wildtyp
mev
strain
clinic
isol
describ
previous
katayama
et
al
strain
belong
mev
genotyp
respect
laboratoryadapt
standard
strain
edmonston
belong
genotyp
also
use
describ
previous
shibahara
et
al
sspe
viru
strain
recent
isol
patient
sspe
belong
genotyp
manuscript
prepar
characterist
similar
strain
sspe
viru
lack
cellfre
viru
product
accumul
mutat
viral
genom
data
shown
encephalomyocard
viru
emcv
strain
member
famili
picornavirida
prepar
describ
previous
song
et
al
taguchi
et
al
use
irrelev
control
viru
studi
serial
dilut
cultur
supernat
cell
infect
wildtyp
mev
inocul
onto
veroslam
cell
viru
adsorpt
done
c
h
cultur
overnight
number
syncytium
form
monolay
cell
count
assess
effect
sirna
sspe
viru
replic
sspe
virusinfect
cell
transfect
either
synthet
sirna
pcpur
express
plasmid
cocultur
fresh
veroslam
cell
overnight
cultur
number
newli
form
syncytia
count
emcv
titer
determin
plaqu
assay
veroslam
cell
describ
previous
minor
modif
song
et
al
taguchi
et
al
first
assess
efficaci
synthet
sirna
design
target
l
mrna
mev
sequenc
posit
sirna
summar
tabl
sirna
target
hepat
c
viru
name
takigawa
et
al
serv
neg
control
initi
experi
veroslam
cell
first
transfect
sirna
h
inocul
strain
mev
h
viru
titer
cultur
supernat
determin
shown
fig
mev
replic
markedli
inhibit
sirna
moder
hand
slightli
inhibit
mev
replic
cell
first
inocul
mev
transfect
sirna
mark
inhibit
mev
replic
sirna
also
observ
treatment
sirna
h
postinfect
effici
inhibit
mev
replic
fig
howev
inhibitori
effect
longer
observ
sirna
ad
cell
h
postinfect
similar
result
obtain
sirna
data
shown
inhibitori
effect
dosedepend
inhibit
dose
nm
fig
construct
pcpur
plasmid
express
test
possibl
inhibitori
effect
mev
replic
sirnaexpress
plasmid
serv
neg
control
veroslam
cell
transfect
express
plasmid
inocul
viru
day
viru
replic
monitor
result
clearli
demonstr
pcpur
sirna
markedli
inhibit
replic
strain
mev
fig
inhibitori
effect
appear
weaker
seri
experi
plasmidbas
sirna
also
inhibit
replic
mev
strain
belong
genotyp
share
target
sequenc
common
genotyp
strain
data
shown
hand
sirna
inhibit
replic
edmonston
strain
belong
genotyp
fig
note
one
two
nucleotid
substitut
target
sequenc
respect
genotyp
hand
target
sequenc
complet
conserv
two
genotyp
expect
replic
unrel
viru
emcv
affect
sirna
fig
result
suggest
mev
sequencespecif
inhibit
sirna
test
see
whether
sirna
either
synthet
pcpur
inhibit
sspe
viru
infect
veroslam
cell
persist
infect
uninfect
cell
transfect
either
synthet
sirna
pcpur
overnight
sirna
either
synthet
plasmidmedi
serv
control
transfect
sspe
virusinfect
cell
cocultur
uninfect
cell
number
syncytium
emerg
monolay
cell
count
h
thereaft
experiment
procedur
use
examin
effect
sirna
viru
multipl
cell
celltocel
viral
spread
result
obtain
clearli
demonstr
synthet
plasmidmedi
sirna
markedli
inhibit
sspe
viru
replic
andor
celltocel
spread
fig
b
next
seri
experi
sspe
viru
veroslam
cell
cultur
persist
infect
transfect
synthet
sirna
h
cell
seed
cocultur
overnight
incub
sirna
cell
refe
fresh
medium
without
contain
sirna
maintain
cultur
observ
syncytium
format
experiment
condit
sspe
viru
replic
infect
cell
markedli
inhibit
synthet
sirna
fig
similarli
pcpur
sirna
brought
effici
inhibit
replic
plasmid
transfect
h
cell
seed
fig
l
protein
mev
rnadepend
rna
polymeras
essenti
viral
rna
replic
yet
least
abund
among
mev
protein
express
barik
lamb
kolakofski
therefor
viral
mrna
encod
l
protein
would
good
target
rnai
strategi
inhibit
replic
mev
sspe
viru
inde
demonstr
present
studi
sirna
target
select
portion
l
mrna
mev
especi
either
synthet
sirna
express
pcpur
plasmid
effect
inhibit
replic
mev
sspe
viru
fig
inhibitori
capac
otherwis
effect
sirna
becam
bare
detect
sirna
transfect
cell
h
mev
infect
fig
result
suggest
viru
replic
reach
maxim
level
viral
mrna
molecul
accumul
abundantli
cell
level
beyond
inhibitori
capac
sirna
idea
might
discourag
attempt
use
sirna
therapeut
purpos
howev
also
state
sirna
render
neighbor
uninfect
cell
resist
viru
infect
prevent
viral
spread
neighbor
cell
fact
spread
sspe
viru
persist
infect
cell
effici
block
sirna
fig
b
also
noteworthi
even
transient
transfect
system
sirna
express
plasmid
introduc
cell
mev
replic
inhibit
veroslam
cell
transfect
pcpur
express
plasmid
gwell
overnight
inocul
strain
mev
h
viru
titer
cultur
supernat
determin
sirnaexpress
plasmid
serv
control
cont
mock
indic
cultur
treat
transfect
reagent
without
sirna
data
repres
mean
sem
obtain
two
independ
experi
express
percentag
number
syncytium
seen
well
treat
sirnaexpress
plasmid
p
compar
control
b
veroslam
cell
transfect
pcpur
express
plasmid
gwell
overnight
inocul
edmonston
strain
mev
genotyp
h
viru
titer
cultur
supernat
determin
data
repres
mean
sem
obtain
two
independ
experi
p
compar
control
c
veroslam
cell
transfect
pcpur
express
plasmid
gwell
overnight
inocul
emcv
h
viru
titer
cultur
supernat
determin
data
repres
mean
sem
obtain
two
independ
experi
sirna
fig
b
like
explan
remark
effici
inhibit
virusinfect
cell
form
syncytia
fusion
neighbor
cell
least
expect
harbor
sirnaexpress
plasmid
de
novoproduc
sirna
introduc
virusinfect
cell
virtu
syncytium
format
although
sirna
may
activ
ifn
system
kim
et
al
sledz
et
al
sirna
use
studi
unlik
induc
ifn
activ
sinc
inhibit
replic
emcv
fig
emcv
known
highli
sensit
ifn
song
et
al
taguchi
et
al
result
also
indic
sirna
use
studi
bring
cytotox
effect
current
satisfactori
specif
treatment
sspe
therefor
rnai
strategi
might
consid
potenti
therapeut
measur
fatal
diseas
sequenc
target
sirna
well
conserv
across
differ
genotyp
wildtyp
mev
sspe
viru
data
shown
consid
effici
silenc
effect
lack
cytotox
togeth
sirna
would
one
good
candid
clinic
trial
howev
number
import
issu
address
recent
report
virus
could
escap
rnai
mutat
target
viral
sequenc
boden
et
al
da
et
al
gitlin
et
al
leonard
schaffer
wilson
richardson
characterist
rna
viru
whose
rnadepend
rna
polymeras
errorpron
sspe
viru
frequent
undergo
genet
mutat
longterm
persist
patient
lamb
kolakofski
therefor
combin
usag
multipl
sirna
target
differ
sequenc
would
recommend
time
possibl
offtarget
effect
sirna
examin
thoroughli
also
need
establish
good
system
effici
introduc
sirna
brain
cell
current
gener
recombin
adenoviru
vector
express
sirna
differ
portion
mevssp
viru
l
mrna
usag
nonvir
vector
organ
modifi
silica
nanoparticl
bharali
et
al
would
anoth
promis
option
case
safeti
vector
appli
vivo
complet
warrant
conclus
develop
sirna
effect
inhibit
replic
mev
sspe
viru
although
number
import
issu
address
possibl
clinic
applic
sirna
may
potenti
candid
therapeut
measur
current
incur
sspe
graduat
school
medicin
fukuoka
japan
provid
pcpur
veroslam
cell
respect
work
support
part
research
program
slow
viru
infect
ministri
health
labour
welfar
japan
also
carri
part
program
kobe
univers
graduat
school
medicin
